Market Overview

UPDATE: KeyBanc Capital Markets Initiates Chemtura at Buy on 2013 Earnings Outlook

Related CHMT
Chemtura Names Simon Medley Executive VP, Industrial Performance Products And Great Lakes Solutions
Benzinga's Top Downgrades

KeyBanc Capital Markets initiated coverage on Chemtura (NYSE: CHMT) with a Buy rating and a $25 price target.

KeyBanc Capital Markets commented, "In our view, CHMT shares offer significant upside to the value investor from today's price of $18.08. Even in the current macro-environment, CHMT should experience solid earnings growth in 2013 resulting from its portfolio management, continuous development of its higher growth businesses and capitalizing on its leverage to favorable global trends, such as increasing environmental regulations and standards. It is true that CHMT is impacted by cyclical markets, like electronics, but we believe that shares and forward expectations now reflect today's weak environment."

Chemtura closed at $18.08 on Thursday.

Latest Ratings for CHMT

DateFirmActionFromTo
Sep 2014KeyBancDowngradesBuyHold
Jul 2013Piper JaffrayMaintainsOverweight
Jun 2013OppenheimerDowngradesMarket PerformUnderperform

View More Analyst Ratings for CHMT
View the Latest Analyst Ratings

Posted-In: KeyBanc Capital MarketsAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (CHMT)

Around the Web, We're Loving...

Get Benzinga's Newsletters